KB Financial Partners’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$90K Buy
963
+125
+15% +$14.1K 0.03% 202
2023
Q2
$108K Buy
838
+53
+7% +$6.41K 0.03% 201
2023
Q1
$91K Hold
785
0.03% 212
2022
Q4
$89K Sell
785
-43
-5% -$4.72K 0.03% 224
2022
Q3
$67K Sell
828
-16
-2% -$1.35K 0.02% 228
2022
Q2
$63K Buy
844
+284
+51% +$25.9K 0.02% 235
2022
Q1
$72K Buy
+560
New +$61.3K 0.02% 240

Other funds holding DXCM

KB Financial Partners's DXCM Position: Q3 2023 in Review

KB Financial Partners increased its DexCom (DXCM) stake by 15% in Q3 2023, buying an estimated $14.1K and bringing the position to 963 shares worth $90K. The position accounts for 0.03% of the portfolio, ranked #202.

KB Financial Partners first reported a position in DXCM in Q1 2022 and has held it in 7 quarters since. The position peaked at $108K in Q2 2023. 903 funds tracked by Wall St. Rank hold DXCM as of Q3 2023.

  • KB Financial Partners held 963 shares of DexCom worth $90K as of Q3 2023.
  • KB Financial Partners bought 125 DexCom shares in Q3 2023, an estimated $14.1K.
  • DexCom made up 0.03% of KB Financial Partners's portfolio in Q3 2023, its #202 holding.
  • KB Financial Partners first reported a position in DexCom in Q1 2022 and has held it in 7 quarters since.
  • KB Financial Partners's DexCom position peaked at $108K in Q2 2023.
  • 903 funds tracked by Wall St. Rank held DexCom as of Q3 2023.

Based on KB Financial Partners's 13F filing for Q3 2023, filed 15 Nov 2023.